000 01526 a2200397 4500
005 20250513061303.0
264 0 _c19930803
008 199308s 0 0 eng d
022 _a1067-5582
024 7 _a10.1097/00002371-199302000-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaylor, D D
245 0 0 _aEnhancement of antitumor effects of combined chemoimmunotherapy.
_h[electronic resource]
260 _bJournal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy
_cFeb 1993
300 _a91-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdjuvants, Immunologic
650 0 4 _aAnimals
650 0 4 _aCD4-Positive T-Lymphocytes
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aDisease Models, Animal
650 0 4 _aFluorouracil
_xtherapeutic use
650 0 4 _aImmunotherapy
650 0 4 _aLevamisole
_xtherapeutic use
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aThymopentin
_xtherapeutic use
700 1 _aGerçel-Taylor, C
700 1 _aFowler, W C
700 1 _aWeese, J L
773 0 _tJournal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy
_gvol. 13
_gno. 2
_gp. 91-7
856 4 0 _uhttps://doi.org/10.1097/00002371-199302000-00003
_zAvailable from publisher's website
999 _c8099770
_d8099770